BLUE


bluebird bio Reports Quarterly Loss, Provides Clinical Updates

This article was originally published on TipRanks.com bluebird bio, Inc.

bluebird bio Sinks 48% on Muted Q3 Results

bluebird bio, Inc. (BLUE), the gene therapy developer for severe genetic disorders and cancer, has reported weaker-than-expected results for the third quarter ended September 30, 2021.

bluebird bio to Resume Marketing of ZYNTEGLO in EU

Biotechnology company bluebird bio, Inc. (BLUE) announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has approved the …

Bluebird Prices New Shares At $55, Seeks To Raise $500 Million

Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.

3 Beaten-Up Biotech Stocks That Just Got More Enticing

The Biotech sector came back to life towards the end of 2019. The Nasdaq Biotechnology Index jumped up 20% between October and December, …

Highlights from ASH Sent bluebird Bio Inc (BLUE) Shares Skyrocketing; J.P. Morgan Cheers

It’s a very rewarding trading day for investors in bluebird bio Inc (NASDAQ:BLUE) with shares up nearly 25%, making the stock Wall Street’s …

Bluebird Bio Inc Gains a New Bull; John Newman Drawn to bb2121’s Long-Term Potential

Canaccord’s John Newman sees 24% upside potential for BLUE shares.

Polar Capital Steps Into Aurinia Pharmaceuticals Inc (AUPH), Kite Pharma Inc (KITE), But Gives bluebird bio Inc (BLUE) the Axe

A First Glance at This Hedge Fund Firm’s Strategic Q2 Moves in Biotech Sector

Thursday’s Market Insights: DryShips Inc. (DRYS), Himax Technologies, Inc. (ADR) (HIMX), bluebird bio Inc (BLUE)

Here’s a Running Tab of Updates Which We Find Most Relevant

Why These Biotech Stocks Tumbled Today: Ocular Therapeutix Inc (OCUL) and bluebird bio Inc (BLUE)

Ocular Therapeutix Inc Ocular Therapeutix Inc (NASDAQ:OCUL) investors seem to be concerned with the company’s future following the news that Antony Mattessich will succeed Dr. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts